Role of complement in enterohemorrhagic escherichia coli -induced hemolytic uremic syndrome

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 4, 2014, Pages 503-507

  Orth Höller, Dorothea ^a   Würzner, Reinhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

complement; factor H family proteins; hemolytic uremic syndrome; membrane bound complement regulators; Shiga toxin

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; FACTOR H LIKE PROTEIN 1; FACTOR H RELATED PROTEIN 1; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; VEROTOXIN 2; CD59 PROTEIN, HUMAN; COMPLEMENT; ECULIZUMAB; MONOCLONAL ANTIBODY; SHIGA TOXIN;

ARTICLE; COMPLEMENT ACTIVATION; DOWN REGULATION; ENDOTHELIUM CELL; ENTEROBACTERIACEAE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; CELL MEMBRANE; CHEMISTRY; GENETICS; GLOMERULUS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUTATION; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD59; CELL MEMBRANE; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY GLOMERULUS; MUTATION; SHIGA TOXIN; SHIGA TOXIN 2;

EID: 84902294881     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1375295     Document Type: Article

References (37)

1. Tarr P. I., Gordon C. A., Chandler W. L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet: 2005; 365 9464 1073 1086
2. Kaplan B. S., Meyers K. E., Schulman S. L. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol: 1998; 9 6 1126 1133
3. European Centre for Disease Prevention and Control and European Food Safety Authority Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104. Stockholm.: 2011
4. Karch H., Tarr P. I., Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol: 2005; 295 6-7 405 418
5. Obrig T. G. Escherichia coli Shiga toxin mechanisms of action in renal disease. Toxins (Basel): 2010; 2 12 2769 2794
6. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem: 1988; 171 1-2 45 50
7. Zimmerhackl L. B., Besbas N., Jungraithmayr T., et al. European Study Group for Haemolytic Uraemic Syndromes and Related Disorders. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost: 2006; 32 2 113 120
8. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med: 2009; 361 17 1676 1687
9. Sánchez-Corral P., Melgosa M. Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome. Br J Haematol: 2010; 150 5 529 542
10. Hofer J., Giner T., Józsi M. Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment. Semin Thromb Hemost: 2014; 40 4 431 443
11. Speth C., Würzner R., Stoiber H., Dierich M. P. Complement. In: Paul W., ed. Fundamental Immunology. Philadelphia, PA Lippincott Williams & Wilkins: 2008; 1047 1078
12. Zipfel P. F., Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol: 2009; 9 10 729 740
13. Skerka C., Chen Q., Fremeaux-Bacchi V., Roumenina L. T. Complement factor H related proteins (CFHRs). Mol Immunol: 2013; 56 3 170 180
14. Zipfel P. F., Skerka C., Hellwage J., et al. Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans: 2002; 30 Pt 6 971 978
15. Kühn S., Skerka C., Zipfel P. F. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J Immunol: 1995; 155 12 5663 5670
16. Heinen S., Hartmann A., Lauer N., et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood: 2009; 114 12 2439 2447
17. Giannakis E., Jokiranta T. S., Male D. A., et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol: 2003; 33 4 962 969
18. Józsi M., Oppermann M., Lambris J. D., Zipfel P. F. The C-terminus of complement factor H is essential for host cell protection. Mol Immunol: 2007; 44 10 2697 2706
19. Oppermann M., Manuelian T., Józsi M., et al. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol: 2006; 144 2 342 352
20. Soames C. J., Sim R. B. Interactions between human complement components factor H, factor I and C3b. Biochem J: 1997; 326 Pt 2 553 561
21. Monnens L., Molenaar J., Lambert P. H., Proesmans W., van Munster P. The complement system in hemolytic-uremic syndrome in childhood. Clin Nephrol: 1980; 13 4 168 171
22. Kim Y., Miller K., Michael A. F. Breakdown products of C3 and factor B in hemolytic-uremic syndrome. J Lab Clin Med: 1977; 89 4 845 850
23. Robson W. L., Leung A. K., Fick G. H., McKenna A. I. Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron: 1992; 62 3 296 299
24. Thurman J. M., Marians R., Emlen W., et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol: 2009; 4 12 1920 1924
25. Ståhl A. L., Sartz L., Karpman D. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood: 2011; 117 20 5503 5513
26. Orth D., Grif K., Khan A. B., Naim A., Dierich M. P., Würzner R. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis: 2007; 59 3 235 242
27. Friedrich A. W., Bielaszewska M., Zhang W. L., et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis: 2002; 185 1 74 84
28. Orth D., Khan A. B., Naim A., et al. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol: 2009; 182 10 6394 6400
29. Markiewski M. M., Lambris J. D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol: 2007; 171 3 715 727
30. Cotran R. S., Pober J. S. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol: 1990; 1 3 225 235
31. Ikeda K., Nagasawa K., Horiuchi T., Tsuru T., Nishizaka H., Niho Y. C5a induces tissue factor activity on endothelial cells. Thromb Haemost: 1997; 77 2 394 398
32. Krisinger M. J., Goebeler V., Lu Z., et al. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood: 2012; 120 8 1717 1725
33. Morigi M., Galbusera M., Gastoldi S., et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol: 2011; 187 1 172 180
34. Poolpol K., Orth-Höller D., Speth C., et al. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family. Mol Immunol: 2014; 58 1 77 84
35. Ehrlenbach S., Rosales A., Posch W., et al. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells. Infect Immun: 2013; 81 8 2678 2685
36. Dammermann W., Schipper P., Ullrich S., et al. Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection. PLoS ONE: 2013; 8 9 e74880
37. Würzner R., Riedl M., Rosales A., Orth-Höller D. Treatment of enterohemorrhagic Escherichia coli- induced hemolytic uremic syndrome (eHUS). Semin Thromb Hemost: 2014; 40 4 508 516